Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026Affirms existing clinical data is sufficient for ...

Our commercial business includes Alarm.com for Business, OpenEye, Checked, and Shooter Detection Systems. These commercial ...

REGENXBIO faces regulatory setbacks for its rare disease drugs, with cash extending only into early 2027. See why RGNX stock ...

Q4 2026 Earnings Call May 19, 2026 7:30 AM EDTCompany ParticipantsVipul Garg - Senior Vice President of Investor ...

Young-Joon Kim underscored the significance of expanded design win activity, stating, "We achieved 71 total design wins in the quarter, up 61% from the 44 design wins in Q2 of last year." Shin Young ...

We examine how AI is changing the future of work — and how, in many ways, that future is already here. Every tech company you can think of is jumping on the generative AI bandwagon and touting new ...

Over the last several years, Apple has dramatically improved how it handles lithium-ion battery charging in iPhones, iPads, Macs, and Apple Watches. Across multiple system releases, the company moved ...

Avacta Therapeutics (AIM: AVCT, 'the Company”, 'Avacta”), a clinical stage biopharmaceutical company developing pre|CISION, a ...

The rule of 72 is a shortcut investors can use to determine how long it will take their investment to double based on a fixed annual rate of return. To use the rule of 72, divide 72 by the fixed rate ...

Earnings call Moderna delivered Q1 2026 revenue of $400 million, up $300 million year-over-year, driven by international partnerships and strong execution, while reiterating up to 10% full-year ...

Ishares Global Aggregate Bond Esg Ucits Etf Usd (dist) is listed on the Euronext Amsterdam trading with ticker code AGGE-USD.AM. It has a market capitalisation of $40.78m, with approximately 10.00m ...

Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated ...